Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Endometrial cancer | R-HSA-2077421 | map05213 | monastrol | 610479 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | monastrol | 610479 | drug-path |
Glioma | Q9NZM4 | map05214 | sulindac sulfide | 31703 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | sulindac sulfide | 31703 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | sulindac sulfide | 31703 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | sulindac sulfide | 31703 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | sulindac sulfide | 31703 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | sulindac sulfide | 31703 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulindac sulfide | 31703 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | exisulind | 3655 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | exisulind | 3655 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | exisulind | 3655 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | exisulind | 3655 | drug-path |
Asthma | R-HSA-444620 | map05310 | exisulind | 3655 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | exisulind | 3655 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | exisulind | 3655 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | exisulind | 3655 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | exisulind | 3655 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | exisulind | 3655 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | exisulind | 3655 | drug-path |